Hair Relaxer Customers Are Developing Cancer At An Alarming Rate

Manufacturers of chemical hair straighteners may have covered up their knowledge that their products lead to developing cancer

Thursday, December 1, 2022 - Men and women who have used chemical hair straighteners either during their work as a beautician, a client, or both, are developing hair relaxer uterine cancer, breast cancer, fibroid tumors, and other life-threatening illnesses at an alarming rate. According to researchers publishing for the National Institute of Health (NIH), "Women who use chemical hair straighteners and relaxers may have a higher risk of uterine cancer." More than 30,000 women were tracked for over a decade and during that time 378 uterine cancer cases were diagnosed according to the NIH. The NIH reported that women using chemical hair straighteners were more than twice as likely to develop the often fatal disease as non-users. "We estimated that 1.64% of women who never used hair straighteners would go on to develop uterine cancer by the age of 70; but for frequent users, that risk goes up to 4.05%," said Alexandra White, Ph.D., head of the NIEHS Environment and Cancer Epidemiology group and lead author on the new study. "This doubling rate is concerning. However, it is important to put this information into context - uterine cancer is a relatively rare type of cancer," the NIH wrote. The NIH also highlighted that the rate of uterine cancer has doubled over the last decade, ", particularly among Black women." It is unproven whether or not chemical hair straightener manufacturers deliberately targeted black women. It is obvious to anyone who looks at the product's packaging, however, that Black women have been deliberately targeted in their advertising.

In response to being alerted that using chemical hair straighteners could have caused cancer, a class action lawsuit has been initiated seeking to pay for ongoing medical monitoring of women who used hair straightening products. Medical monitoring is essential to diagnose uterine cancer, breast cancer, and fibroid tumors at the earliest stage. Early detection is crucial to successfully treating all forms of cancer. Individual lawsuits are being filed against L'Oreal, Softsheen Carson, Inc., and other cosmetic manufacturers for failing to warn their customers. Thousands of individual hair relaxer lawsuits are expected to be filed in the coming year as word about the lethality of chemical hair relaxers gets around. Women with uterine or breast cancer may seek to be reimbursed for medical expenses, lost income, pain and suffering, and also may seek punitive damages to punish the companies for their reprehensible corporate conduct. The cases may be consolidated into multidistrict litigation (MDL) because they involve plaintiffs with similar injuries who used identical products made by the same defendants. MDL saves the court system thousands of hours by consolidating the cases and not replicating administrative procedures. MDL may also serve to control and limit the testimony of expert scientific witnesses to only those who pass muster. MDL also could require attorneys from each side to put forth their best cases to serve as bellwether trials that could influence future court outcomes or facilitate a quick defense settlement offer. There is a motion to consolidate national hair relaxer lawsuits into MDL in the U.S. District Court for the Northern District of Illinois.

More Recent Hair Relaxer Cancer Lawsuit News:

Lawyers for Hair Relaxer Cancer Lawsuits

We will represent all persons involved in a hair relaxer cancer lawsuit on a contingency basis, meaning our lawyers never charge legal fees unless we win compensation in your case. For a free no-obligation consultation please fill out our short online contact form and one of our hair relaxer attorneys for uterine cancer or breast cancer will contact you to answer any of your questions.